|
SC Chow, and Mark Chang.(2008). “Adaptive design methods in clinical trials - a review”, Orphanet J Rare Dis, 3, 3-11.
Mark Chang.(2014). “Adaptive design theory and implementation using SAS and R (2nd ed.)”. New York: Chapman & Hall/CRC.
L Cui, H M Hung, S J Wang.(1999). “Modification of sample size in group sequential clinical trials”, Biometrics, 55(3), 853-857.
H M James Hung, Robert T O’Neill, Sue-Jane Wang, John Lawrence.(2006).“A Regulatory View on Adaptive/Flexible Clinical Trial Design”, Biom J, 48(4), 565-573.
Paul Gallo, Christy Chuang-Stein, Vladimir Dragalin, Brenda Gaydos, Michael Krams, José Pinheiro, PhRMA Working Group.(2006). “Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group”, J Biopharm Stat, 16(3), 275-283.
Mark Chang, Shein-Chung Chow, Annpey Pong.(2006). “Adaptive design in clinical research: issues, opportunities, and recommendations”, J Biopharm Stat, 16(3), 299-309; discussion 311-312.
Andrea Burton 1, Douglas G Altman, Patrick Royston, Roger L Holder.(2006).” The design of simulation studies in medical statistics”, Stat Med, 25(24), 4279-4292.
Guoqiao Wang, Richard E.Kennedy, Gary R.Cutter, Lon S.Schneider.(2015)” Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment” Alzheimer's & Dementia: Translational Research & Clinical Interventions, 1(1), 63-71.
Francesca Galli, Luigi Mariani.(2014).” Two-stage re-estimation adaptive design: A simulation study” Epidemiology Biostatistics and Public Health, 11(1), https://doi.org/10.2427/8862
郭英調、黃欣儀.(2014).”臨床研究手冊”,九州圖書文物有限公司。
|